Plastic Surgeons Association Revises Position on Gender-Affirming Surgeries for Adolescents

Overview

The American Society of Plastic Surgeons (ASPS) now recommends delaying gender-affirming surgeries until age 19 due to insufficient evidence supporting benefits over risks in minors. This stance diverges from other major medical organizations that support case-by-case decisions and cautious access to such care for adolescents.

Background

Gender-affirming surgeries for adolescents with gender dysphoria have been a contentious issue amid political and medical debates. While some organizations endorse individualized care plans including surgery, the ASPS has revised its position citing recent reviews and reports that question the evidence of benefit in minors. The Trump administration has also pressured healthcare providers to limit gender-affirming care for youth, leading to some hospitals suspending such treatments. Other professional groups emphasize multidisciplinary evaluation and caution rather than blanket age restrictions.

Data Highlights

Gender-affirming surgery is rare among U.S. children, with fewer than 1 in 1,000 adolescents receiving gender-affirming medications. The ASPS based its revised position on the Cass Review (England) and a 2025 U.S. Department of Health and Human Services report, both highlighting insufficient evidence of benefit over risk for surgeries in minors.

Key Findings

• The ASPS recommends delaying chest, genital, and facial gender-affirming surgeries until patients reach 19 years old.
• The society found insufficient evidence that benefits of these surgeries outweigh risks in minors.
• The position statement is not a clinical guideline and was developed without an independent evidence assessment.
• Other major medical organizations, including the American Academy of Pediatrics and WPATH, support cautious, individualized surgical decisions without strict age cutoffs.
• The Trump administration has pressured healthcare providers to limit gender-affirming care for minors, influencing some hospitals to suspend such treatments.
• The ASPS acknowledges legal and regulatory variability contributes to ethical and clinical risks in surgical decision-making for minors.

Clinical Implications

Clinicians should recognize the ASPS's revised position as a recommendation rather than a guideline, emphasizing the need for careful risk-benefit analysis before performing gender-affirming surgeries on adolescents. Multidisciplinary evaluation and individualized care remain critical, especially given differing stances among professional organizations and evolving legal contexts. Providers should stay informed on emerging evidence and regulatory changes impacting gender-affirming care for youth.

Conclusion

The ASPS's updated position reflects ongoing uncertainty and debate regarding gender-affirming surgeries in minors, underscoring the importance of balancing compassion with scientific rigor and legal considerations. Continued research and consensus-building are needed to guide ethical and effective care for transgender adolescents.

References

1. Associated Press Health and Science Department 2025 -- Plastic Surgeons Association Revises Position on Gender-Affirming Surgeries for Adolescents